(Q85283303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Meidong Zhu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jamie K Chew

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Geoffrey K Broadhead

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Kehui Luo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Nichole Joachim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Thomas Hong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Adil Syed

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Andrew A Chang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

10 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1217-1225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25205618%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00417-014-2799-8

16 February 2020

exact match

0 references

cites work

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial

1 reference

12 December 2020

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

1 reference

12 December 2020

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis

1 reference

12 December 2020

Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments

1 reference

12 December 2020

Intravitreal injections: is there benefit for a theatre setting?

1 reference

12 December 2020

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration

1 reference

12 December 2020

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study

1 reference

12 December 2020

Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials

1 reference

12 December 2020

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

12 December 2020

A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.

1 reference

12 December 2020

Current knowledge and trends in age-related macular degeneration: today's and future treatments.

1 reference

12 December 2020

Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration

1 reference

12 December 2020

Age-related macular degeneration

1 reference

12 December 2020

Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration

1 reference

12 December 2020

Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

1 reference

12 December 2020

Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy

1 reference

12 December 2020

Prevalence of age-related macular degeneration in the US population

1 reference

12 December 2020

Four-year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment

1 reference

12 December 2020

Comparison of time domain and spectral domain optical coherence tomography in measurement of macular thickness in macular edema secondary to diabetic retinopathy and retinal vein occlusion

1 reference

12 December 2020

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

1 reference

12 December 2020

Reproducibility of segmentation error correction in age-related macular degeneration: Stratus versus Cirrus OCT.

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments.

1 reference

12 December 2020

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration

1 reference

12 December 2020

No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting

1 reference

12 December 2020

Novel method for analyzing snellen visual acuity measurements

1 reference

12 December 2020

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

1 reference

12 December 2020